Albert I. Wertheimer
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Albert I. Wertheimer has a total of 4 co-authors. Here are the top co-authors by number of shared publications:
- Leanne Lai
College of Pharmacy, Kaohsiung Medical University, Kaohsiung, Taiwan
1 shared publication - Nathaniel M. Rickles
University of Connecticut, 69 North Eagleville Road, Unit 3092, Storrs, CT
1 shared publication - Will Wang
Touro College of Pharmacy, New York, NY, USA
1 shared publication - Yifan Huang
Department of Pharmacy Practice, University of Connecticut, Storrs, CT 06269, USA
1 shared publication
Latest Publications
- 1 May 2022
- Published by Elsevier in Research in Social and Administrative Pharmacy
- Vol. 18 (5) , 2811-2816
History, status, and politicization of the FDA
- 1 May 2022
- Published by Elsevier in Research in Social and Administrative Pharmacy
- Vol. 18 (5) , 2811-2816
History, status, and politicization of the FDA
- 1 November 2021
- Published by Oxford University Press (OUP) in Journal of Pharmaceutical Health Services Research
- Vol. 12 (4) , 473
18 Million in the USA cannot afford needed drugs
The editor recently came across a disturbing report regarding an estimated 18 million Americans who cannot pay for their needed medications. This is a very unfortunate situation, especially for a wealthy country such as the USA. That report from West Health and the Gallup Survey was dated September 2021. The main finding of the report was that in June 2021, 7% of US adults reported that during the previous 3-month period that they were unable to pay for at least one doctor-prescribed medication for someone in their household. Moreover, in households with annual income less than US$24 000, the percentage grows up to 19%. This does not speak well for medication security. As might be expected, the percentages were inversely proportional to annual income levels. However, age tells a different story. Persons aged 18–64 years had about an 8% amount of inability to pay episodes, while those 65 and over...
- 1 November 2021
- Published by Oxford University Press (OUP) in Journal of Pharmaceutical Health Services Research
- Vol. 12 (4) , 473
18 Million in the USA cannot afford needed drugs
The editor recently came across a disturbing report regarding an estimated 18 million Americans who cannot pay for their needed medications. This is a very unfortunate situation, especially for a wealthy country such as the USA. That report from West Health and the Gallup Survey was dated September 2021. The main finding of the report was that in June 2021, 7% of US adults reported that during the previous 3-month period that they were unable to pay for at least one doctor-prescribed medication for someone in their household. Moreover, in households with annual income less than US$24 000, the percentage grows up to 19%. This does not speak well for medication security. As might be expected, the percentages were inversely proportional to annual income levels. However, age tells a different story. Persons aged 18–64 years had about an 8% amount of inability to pay episodes, while those 65 and over...
- 1 November 2020
- Published by Oxford University Press (OUP) in Journal of Pharmaceutical Health Services Research
- Vol. 11 (4) , 305
Complexities in pharmaceutical health services research
- 1 November 2020
- Published by Oxford University Press (OUP) in Journal of Pharmaceutical Health Services Research
- Vol. 11 (4) , 305
Complexities in pharmaceutical health services research
- 1 September 2020
- Published by Oxford University Press (OUP) in Journal of Pharmaceutical Health Services Research
- Vol. 11 (3) , 195-196
The drug situation in lesser developed countries
- 1 September 2020
- Published by Oxford University Press (OUP) in Journal of Pharmaceutical Health Services Research
- Vol. 11 (3) , 195-196
The drug situation in lesser developed countries
- 13 July 2020
- Published by Oxford University Press (OUP) in Journal of Pharmaceutical Health Services Research
- Vol. 11 (3) , 231-235
The pharmacists' contribution against opioid addiction
Objectives: The aim of this study was to investigate pharmacists' willingness to consider suggesting a non-narcotic NSAID medication instead of an opioid for patients requiring pain relief. Specifically, the study aimed to extend the vital role of the pharmacist in helping to alleviate the opioid crisis. Methods: A cross-sectional survey was conducted by a University Continuing Pharmacy Education Office (response rate = 66%). Key findings: Although 84.1% of respondents were willing to suggest NSAID replacement to patients, they appeared to be a bit less optimistic to patient's response, and only 13.5% of them felt that more than half of their patients would go along with the NSAID suggestion. There was no statistically significant difference in the responses of female and male pharmacists. The relatively older pharmacists tended to be more likely to consult their patients about this issue compared with younger pharmacists. This may be due to greater confidence that accompanies greater experience or the fact that they had longer relationships with their patients. Conclusions: While opioid addiction occurs from numerous sources, the partial elimination of opioid prescriptions by pharmacists could possibly reduce in some modest way the total number of persons exposed to opioids.
- 13 July 2020
- Published by Oxford University Press (OUP) in Journal of Pharmaceutical Health Services Research
- Vol. 11 (3) , 231-235
The pharmacists' contribution against opioid addiction
Objectives: The aim of this study was to investigate pharmacists' willingness to consider suggesting a non-narcotic NSAID medication instead of an opioid for patients requiring pain relief. Specifically, the study aimed to extend the vital role of the pharmacist in helping to alleviate the opioid crisis. Methods: A cross-sectional survey was conducted by a University Continuing Pharmacy Education Office (response rate = 66%). Key findings: Although 84.1% of respondents were willing to suggest NSAID replacement to patients, they appeared to be a bit less optimistic to patient's response, and only 13.5% of them felt that more than half of their patients would go along with the NSAID suggestion. There was no statistically significant difference in the responses of female and male pharmacists. The relatively older pharmacists tended to be more likely to consult their patients about this issue compared with younger pharmacists. This may be due to greater confidence that accompanies greater experience or the fact that they had longer relationships with their patients. Conclusions: While opioid addiction occurs from numerous sources, the partial elimination of opioid prescriptions by pharmacists could possibly reduce in some modest way the total number of persons exposed to opioids.
- 1 July 2020
- Published by Oxford University Press (OUP) in American Journal of Health-System Pharmacy
- Vol. 77 (13) , 1066-1069
Thinking globally to meet pharmacy's universal challenges
I have been a pharmacist for just over 50 years. I have lectured or consulted in over 70 countries and have guided master’s, PhD, and postdoctoral students from about 30 countries, so I feel qualified to discuss global pharmacy with you today. Pharmaceutically speaking, I come from a backward country. I will explain that statement in a few minutes. In the United States, we are taught that we are at the top and do things as leaders and set examples for the rest of the world. In some areas that is true. However, in pharmacy it is not so accurate. I have learned over and over a simple lesson that the problems surrounding and...
- 1 July 2020
- Published by Oxford University Press (OUP) in American Journal of Health-System Pharmacy
- Vol. 77 (13) , 1066-1069
Thinking globally to meet pharmacy's universal challenges
I have been a pharmacist for just over 50 years. I have lectured or consulted in over 70 countries and have guided master’s, PhD, and postdoctoral students from about 30 countries, so I feel qualified to discuss global pharmacy with you today. Pharmaceutically speaking, I come from a backward country. I will explain that statement in a few minutes. In the United States, we are taught that we are at the top and do things as leaders and set examples for the rest of the world. In some areas that is true. However, in pharmacy it is not so accurate. I have learned over and over a simple lesson that the problems surrounding and...
- Open Access
Training Community Pharmacy Staff How to Help Manage Urgent Mental Health Crises
Nearly 44 million Americans are affected by mental illness every year. Many individuals, however, are not diagnosed and/or do not receive treatment. The present manuscript reviews the incidence of mental illness, the continuum from mental wellness to mental illness, and the role of the pharmacy staff in helping individuals manage different mental health needs. In particular, there is discussion of stigma of mental illness that those with mental health needs experience by those around them including health professionals such as pharmacy staff. One way to resolve such stigma is through training such as Mental Health First Aid (MHFA). The paper reviews key aspects of MHFA, the evidence supporting MHFA, and how MHFA relates specifically to pharmacy practice and services. A conceptual framework for MHFA and its relationship to individual factors, attitudes, behaviors, and outcomes. Lastly, a discussion is presented that briefly compares MHFA to other similar approaches to helping those in mental health crises, the limits of what is known about MHFA, and what future research might explore to better understand the outcomes of pharmacy staff providing mental health education, support, and referral to care.
Open AccessTraining Community Pharmacy Staff How to Help Manage Urgent Mental Health Crises
Nearly 44 million Americans are affected by mental illness every year. Many individuals, however, are not diagnosed and/or do not receive treatment. The present manuscript reviews the incidence of mental illness, the continuum from mental wellness to mental illness, and the role of the pharmacy staff in helping individuals manage different mental health needs. In particular, there is discussion of stigma of mental illness that those with mental health needs experience by those around them including health professionals such as pharmacy staff. One way to resolve such stigma is through training such as Mental Health First Aid (MHFA). The paper reviews key aspects of MHFA, the evidence supporting MHFA, and how MHFA relates specifically to pharmacy practice and services. A conceptual framework for MHFA and its relationship to individual factors, attitudes, behaviors, and outcomes. Lastly, a discussion is presented that briefly compares MHFA to other similar approaches to helping those in mental health crises, the limits of what is known about MHFA, and what future research might explore to better understand the outcomes of pharmacy staff providing mental health education, support, and referral to care.